Table 1 Surveillance options for IP malignant transformation
Clinical investigation options | Endoscopy |
Computed Tomography | |
Magnetic Resonance Imaging | |
PET-CT with FDG | |
Biologic markers | Genetic factors (P53, P21, MSX2, PDCD4, KRAS, PTEN) |
Proteins (SCCa, fascin, surviving, COX-2, cell adhesion molecules, Ki-67 etc) | |
Viral (HPV, EBV) |